KBI Biopharma Awarded as Global Leader in Biologics Manufacturing

Durham, North Carolina (April 3, 2025)—KBI Biopharma, a JSR Life Sciences Company and leading global contract development and manufacturing organization (CDMO), has been recognized as a top performer in biologics manufacturing on a global scale in the 2025 CDMO Leadership Awards. The prestigious awards, presented by Outsourced Pharma and Life Science Connect, identify the top CDMOs worldwide based on in-depth customer feedback and evaluations.

KBI Biopharma was evaluated alongside 210 CDMOs through a survey of 289 respondents. Participants rated only those CDMOs with whom they had collaborated on outsourced projects within the past 24 months. Survey responses were converted into Net Promoter Scores (NPS), with the highest-performing companies earning a ‘Top 3 Ranking.’ Each CDMO then received a final weighted score (1–10), and only those surpassing the qualification threshold in their respective categories were designated as winners.

"We are proud to be named a global leader in biologics manufacturing," said Tim Lowery, CEO of KBI Biopharma. "I'd like to extend my gratitude to our customers for providing valuable feedback about their experience with our team. This accolade is a testament to our employees' unwavering commitment to providing innovative scientific solutions and exceptional support, accelerating our customers' drug development and commercialization efforts.

The CDMO Leadership Awards are based on research by Orientation Marketing, who surveyed pharmaceutical and biotech decision-makers on their contract manufacturing partners. KBI Biopharma stood out for consistently exceeding customer expectations and building strong, collaborative relationships.

“For the 14th annual Outsourced Pharma CDMO Leadership Awards, we’ve added innovation to the way we select award winners, and excitement to how we will reveal those winners. The innovation comes with new award categories and enhanced scoring methodology. The added excitement is because our final Champion Award winners will only be revealed at our NYC event on March 19th. We are still the most important development and manufacturing outsourcing awards in the industry. But now more meaningful than ever.” - Louis Garguilo, Chief Editor, Outsourced Pharma. For more information about the innovative biologic solutions offered by KBI Biopharma click here.

About KBI Biopharma

KBI Biopharma, Inc., a JSR Life Sciences company, together with its affiliates, is a global contract development and manufacturing organization (CDMO) providing fully integrated, accelerated drug development and biologics manufacturing services and expertise to life science companies. As a global leader in mammalian cell line development, with best-in-class modular technology and highly specialized solutions, KBI enables the life sciences industry to rapidly discover, develop, and commercialize innovative medicines and vaccines. With each of its 500+ customer partners, KBI works closely to personalize and rapidly accelerate drug development programs.

Global partners are utilizing KBI’s technologies to advance more than 170 drug candidates in preclinical and clinical development and the manufacture of ten commercial products. Built upon a foundation of world-class analytics capabilities and extensive scientific and technical expertise, KBI delivers robust process development and clinical and commercial cGMP manufacturing services for mammalian and microbial programs. Recognized for quality manufacturing, KBI helps partners advance drug candidates to the market. KBI serves its global customers with six locations in Europe and the USA. More information is available at www.kbibiopharma.com.

Media Inquiries:

KBI Biopharma

Sarah Martin-Tyrrell